Apyx Medical Corp - Common Stock, $0.001 par value per share (APYX)

CUSIP: 03837C106

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-290,562
Put/Call ratio
0.46%
SEC-reported price per share
$1.24
Number of holders
45
Value change
-$371,477
Number of buys
10
Open additional details 1 more signal available
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
42,231,815

Security key

03837C106

Report period

Q3 2024

Institutions

45

Top holders

10

Ownership snapshot

Top reported holders of APYX - Apyx Medical Corp - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Archon Capital Management...
Disclosed value leader
Archon Capital Management...
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $4,174,477 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Archon Capital Management LLC has the largest disclosed position value at $4.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Archon Capital Management LLC's linked filing trail.
Disclosed position value Top 5
Archon Capital Management LLC $4.17M
ROYCE & ASSOCIATES LP $3.35M
VANGUARD GROUP INC $1.98M
Taylor Frigon Capital Management LLC $858.4K
HORIZON KINETICS ASSET MANAGEMENT... $824.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Archon Capital Management LLC
13F
Company
13F
—
denominator unverified
$4,174,477
3,115,281 shares
— 30 Jun 2024
ROYCE & ASSOCIATES LP
13F
Company
13F
—
denominator unverified
$3,346,279
2,497,223 shares
— 30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,984,384
1,480,884 shares
— 30 Jun 2024
Taylor Frigon Capital Management LLC
13F
Company
13F
—
denominator unverified
$858,358
640,566 shares
— 30 Jun 2024
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$824,100
615,000 shares
— 30 Jun 2024
Silverberg Bernstein Capital Management LLC
13F
Company
13F
—
denominator unverified
$799,293
596,487 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
45
Shares
12,800,031
Rows available
45
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
49
Q3 2024 holders
45
Holder diff
-4
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .